Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
State Approaches to Tackling the Opioid Crisis Through the Health Care System
States have implemented multiple strategies to enhance the capacity and quality of treatment services for opioid use disorder.
-
Pacula Examines Pitfalls in the Legalized Marijuana Marketplace
As the marijuana industry marches toward mainstream acceptance, policymakers are turning to Rosalie Liccardo Pacula to help ensure that its popularity does not outpace scientific understanding of its risks.
-
Age Differences in COVID-19 Risk Perceptions and Mental Health: Evidence From a National U.S. Survey Conducted in March 2020
U.S. adults who were relatively older appeared to have a more optimistic outlook and better mental health during the early stages of the pandemic.
Categorized in -
Association of Combination Statin and Antihypertensive Therapy With Reduced Alzheimer’s Disease and Related Dementia Risk
Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.
Categorized in -
Without Oversight, Electronic Prescribing Can Harm Patients
To protect patients from addiction, overdose, and even death, it may be necessary to rein in health information technology — or at least modify it.
Categorized in -
Helping Consumers Understand the Real Costs of Credit Cards
If consumers are to make informed choices about credit cards and other financial products, they need to understand how much these products cost them over time.
Categorized in -
Potential Impacts of Recreational Marijuana Policies and Regulatory Structures that Could Reduce its Negative Impacts
Rosalie Liccardo Pacula presented before the Florida House of Representatives Health & Human Services Committee, Subcommittee on Health Quality on Dec. 11, 2019 about regulations to govern the use of recreational marijuana.
-
Does the Market Reward Quality?: Evidence from India
There are two salient facts about health care in low and middle-income countries; 1) the private sector plays an important role and 2) the care provided is often of poor quality.
Categorized in -
Economic Value of Anti–Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States
A new study suggests benefits to patient health and society top billions of dollars, or more, if adherence to wet age-related macular degeneration treatments could be improved.
Categorized in -
Treatments for the Leading Cause of Blindness in the US Generate $0.9 to $3 Billion for Society, According to New Economic Analysis
A new study suggests benefits to patient health and society top billions of dollars, or more, if adherence to wet age-related macular degeneration treatments could be improved.
Categorized in